Klox Technologies Competitors and Similar CompaniesClear all

Klox Technologies's competitors and similar companies include NanoString, BrainXell, Axsome Therapeutics and Southern Research.

	Klox Technologies Klox Technologies is a regenerative medicine company.	NanoString NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics.	BrainXell BrainXell is a company that provides products and services for neuroscience research.	Axsome Therapeutics Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system disorders.	Southern Research Southern Research (SR) Institute is a non-profit scientific and engineering research organization.
Founding Date	Founding Date 2007	Founding Date 2003	Founding Date 2015	Founding Date 2012	Founding Date 1941
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare clinical research drug development genetics healthtech life sciences	Tags Healthcare biotech clinical research genetics healthtech life sciences medical diagnostics medical imaging nanotech	Tags Healthcare biotech clinical research drug development genetics	Tags Healthcare biotech clinical research drug development healthtech life sciences pharma therapy	Tags Healthcare clinical research drug development life sciences medical diagnostics
Locations	Locations Laval, CA HQ Ballerup, DK Assago, IT Chevy Chase, US	Locations Seattle, US HQ Amsterdam, NL	Locations Madison, US HQ	Locations New York, US HQ New York, US	Locations Birmingham, US HQ
Employees	Employees 17	Employees 7038% decrease	Employees 50	Employees 4111% increase	Employees 4632% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 5.1 m	Valuation ($) N/A	Valuation ($) 4.3 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $127.3m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $638.5m (FY, 2025)	Revenue (est.) $31.8m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods $65.5m (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods $20.2m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit $61.8m (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit $11.6m (FY, 2024)
Net income	Net income N/A	Net income ($159.5m) (FY, 2022)	Net income N/A	Net income ($183.2m) (FY, 2025)	Net income $2.7m (FY, 2024)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 152m	Total funding raised N/A	Total funding raised $ 7m	Total funding raised $ 2.8m